MedTech Dive January 25, 2024
Nick Paul Taylor

The reorganization establishes new divisions at the Office of Strategic Partnerships and Technology Innovation to account for its growth since 2019.

Dive Brief:

  • The Food and Drug Administration has elevated and expanded an office that handles activities including medical device cybersecurity and digital health.
  • Effective immediately, the Office of Strategic Partnerships and Technology Innovation (OST) has become a “super office.” The reorganization creates new divisions and programs at the OST to account for its growth since 2019 and raise the profile of digital health work.
  • The five offices housed in the OST will lead the FDA’s medical device resilient supply chain and shortages program, drive the development of voluntary consensus standards and work on new approaches to digital health...

Today's Sponsors

Venturous
ZeOmega

Today's Sponsor

Venturous

Continue Reading

 
Topics: Cybersecurity, FDA, Govt Agencies, Health IT, Medical Devices, Supply Chain, Technology
Related Articles:
FDA guidance eases wearables oversight. But experts have questions about what’s next.
AI Model FDA-Cleared to Triage 14 Conditions
The Promise And Perils Of FDA’s New ‘Plausible Mechanism’ Pathway (Part 2)
FDA Updates Two Digital Health Final Guidance Documents
FDA in Flux — January 2026 Newsletter

Share Article